̽»¨Ö±²¥

RegGenome, a commercial spin-out from the ̽»¨Ö±²¥ of Cambridge, has announced the completion of a $6 million seed funding round.

Cambridge Enterprise, the commercialisation arm of the ̽»¨Ö±²¥ of Cambridge, has announced the appointment of Dr Christine Martin as Head of Seed Funds.

BKwai, a construction data company that helps engineers develop smarter, more sustainable infrastructure, has raised £2.2 million in seed funding from investors led by Octopus Ventures with participation from Cambridge Enterprise and Deeptech Labs.

Prime Minister Boris Johnson announced that DIOSynVax, a biotech spinout of the ̽»¨Ö±²¥ of Cambridge, will receive $42 million (about £32 million) to develop a vaccine candidate that could provide protection against both existing and future variants of SARS-CoV-2 – the virus that causes COVID-19 – as well as other major coronaviruses, including those that cause SARS and MERS.

A ̽»¨Ö±²¥ of Cambridge spin-out company from the Cavendish Laboratory, combines materials engineering and cell biology to help biopharma companies make better medicines, faster. It announced today that it has closed a £2.14 million seed funding round.

Zero-carbon refrigeration pioneer Barocal has secured a £1.3 million investment to accelerate commercialisation of its novel technology designed to cut global COâ‚‚ emissions. As the technology also works in heating applications, the ̽»¨Ö±²¥ of Cambridge spin-out now plans to explore the potential of its breakthrough for domestic and commercial heating systems—to provide a cost-effective, efficient alternative to expensive air source heat pumps.

Meet the young biotech entrepreneur with two companies to her name and a plan to revolutionise the way we manage our health.

Cambridge spin-out Zetta Genomics has raised £2.5 million in new seed funding from Nina Capital, APEX Medical and Cambridge Enterprise to advance its genomic data management technology and power the discovery and delivery of precision medicine at scale.

Safety trials are underway for a vaccine developed by Cambridge researchers that could be used as a booster targeting COVID-19 virus variants and relatives that threaten future coronavirus pandemics.

̽»¨Ö±²¥first three spin-out companies have been launched from a government-backed knowledge exchange partnership designed to revolutionise the creation and uptake of early-stage agricultural technology (agri-tech) opportunities.